Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREAT-SVDs
2016-002920-10Phase 3Terminated
- Sponsor
- LMU Klinikum
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Cerebral Small Vessel Disease (CSVD) comparing amlodipine arm, losartan arm and atenolol arm (3 arms). Primary endpoint: cerebrovascular reactivity (BOLD MRI). Started Aug 2016; status: terminated.
02
Drugs
amlodipinelosartanatenolol
03
Conditions
Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on 2016-002920-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002920-10.